The Versius robot at the Milan Polyclinic, first time in a public hospital

The Versius * surgical robot will operate for the first time in an Italian public hospital. Cmr Surgical (Cmr), an international robotic surgery company, today announced the introduction of the Versius surgical robotic system at the Irccs Policlinico in Milan, one of the largest healthcare facilities in Lombardy. Versius will be used to develop a multi-specialty program involving Thoracic Surgery and General Surgery. The Italian market of surgical robotics – explains the company in a note – is one of the largest in Europe and characterized by the adoption of cutting-edge technologies. In Lombardy, in particular, there is the highest concentration of surgical robots in Italy, even if 73% of minimally invasive surgery procedures with the aid of the robot are performed in private facilities. The Milan Polyclinic is the first public hospital in Italy to use Versius, potentially allowing more and more patients to have access to minimally invasive robotic surgery. “It is wonderful to know that Versius will be used within the Polyclinic of Milan, one of the hospitals. historical and most avant-garde in Italy – comments Mark Slack, Chief Medical Officer of Cmr Surgical – The concept of collaboration is fundamental for us at Cmr because it represents a great added value that allows us to improve the quality of services more and more Robotic surgery. With its attitude to patient safety and high quality training, a leading hospital such as the Policlinico di Milano is the ideal facility to partner with to show the potential of Versius and provide surgeons with the ability to use firsthand this new generation robotic technology to perform minimally invasive surgery treatments “. “We are pleased to be the first – underlines Luigi Boni, director of the General Surgery Unit of the Polyclinic of Milan – to have the opportunity to use a new cutting-edge surgical technology. The installation of the Versius robot, the first alternative to robotic system hitherto available on the market in a public facility such as the Policlinico di Milano, could increase the chances of access to these new technologies by all citizens. Robotic surgery, used in association with laparoscopic procedures, could also contribute to improve the clinical outcomes of patients who access these interventions through the national health system. “Within the Polyclinic of Milan, Versius will be used in a series of procedures including cholecystectomy, low anterior resection and pulmonary resection, a surgical procedure used in the treatment of lung cancer. The use of minimally invasive robotic surgery in these cases can significantly reduce the physical effort of the surgeon during the execution of the surgery. It has also been shown that compared to open surgery, minimally invasive surgery reduces the patient’s stay in hospital – from weeks to days – and can reduce the risk of surgical site infections, a problem that is estimated to cost healthcare services. throughout Europe up to 19 billion euros a year. The professor said: “Lombard health care has always shown great interest in robotic surgery – says Mario Nosotti, director of the Thoracic Surgery and Lung Transplantation Unit of the Policlinico di Milano – The installation of the Versius robot and in general the implementation of these advanced medical tools represent a huge step forward for public health. The minimally invasive approach of these technologies in more complex surgical procedures, such as thoracic surgery, will allow to reduce post-operative hospitalization times, resulting in a great advantage both for the patient and for the whole health system. Finally, the accuracy of the surgical gesture is amplified by the robotic instrument, resulting in even more effective and radical interventions. “Versius is already used in several hospitals in Europe, India, Australia and the Middle East, where he was used to perform numerous gynecological, general, thoracic and urological surgery procedures.